Delivery Order SPE2DB24D1205-SPE2DB25FCVKX

Award Date 4/1/25
Potential Completion Date 4/22/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,015.80, is for the delivery of TASIGNA 150 MG CAPSULE 28S, a prescription medication. This is a firm fixed-price delivery order contract with an ultimate completion date of April 21, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen also...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order with a firm fixed price of $11,638.02 and a completion date of March 25, 2025. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply TASIGNA 150 MG CAPSULE 28S. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
This federal contract award, valued at $5,819.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product, to support military healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $12,015.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567751543 ! TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product. The contract has an ultimate completion date of April 21, 2025 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp...
This federal contract award, valued at $5,819.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product. The contract has an ultimate completion date of March 24, 2025 and is a Firm Fixed Price contract. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp...
This federal contract award, valued at $11,638.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TASIGNA 200 MG CAPSULE 28S, a pharmaceutical product, and has a completion date of March 3, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TASIGNA 150 MG CAPSULE 28S. The contract has a ceiling value of $16,873.86 and an ultimate completion date of October 2, 2024. It is a firm fixed-price contract for the delivery of these prescription drug products. The contract is not set aside for any specific business category. AmerisourceBergen, through its extensive supply chain network,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,819.01 firm fixed-price contract is for the supply of TASIGNA 150 MG CAPSULE 28S, a specialty medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $5,819.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it covers the supply of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of January 28, 2025, and it is not designated as a...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,007.90 firm fixed-price delivery order is for the supply of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product. The contract has an ultimate completion date of April 18, 2025 and was awarded on March 28, 2025. There is no set-aside designation associated with this award. AmerisourceBergen holds a $999,999,999...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCVKX
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,015.80, is for the delivery of TASIGNA 150 MG CAPSULE 28S, a prescription medication. The contract has an ultimate completion date of April 22, 2025 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. There is no set-aside designation for this specific award.

Generated 7/1/25, 8:32 AM